Advertisement

Topics

Celgene Corporation Company Profile

15:36 EDT 18th June 2018 | BioPortfolio

Celgene is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases.Celgene's medical research and development team is working to extend the boundaries in the areas of small molecule immunotherapeutic and biocatalytic chiral chemistry by developing both new pharmaceuticals and chirally pure versions of existing drugs. Celgene's agrochemical unit, Celgro, is dedicated to the development of chirally pure crop protection agents.



Our goal is to provide hope and ease suffering through the discovery and development of products for therapies for patients with severe and difficult to treat diseases.

Location

86 Morris Avenue
Summit
NJ
07901
United States of America

Contact

Phone: 1-908-673-9000
Fax: 908 271 4184


News Articles [722 Associated News Articles listed on BioPortfolio]

Celgene Corporation To Acquire Juno Therapeutics For $9B

NewsThe acquisition will add a novel scientific platform and manufacturing capabilities to Celgene’s research and operational activities. Upon completion, Celgene will strengthen its position in cel...

CELGENE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of ...

Celgene investors should visit us at https://www.claimsfiler.com/cases/view-celgene-corporation-securities-litigationor call to speak to our claim center toll-free at (844) 367-9658.   About the L...

Celgene set to challenge Incyte and Novartis in the myelofibrosis landscape

On January 7th 2018, Celgene and Impact Biomedicines announced the signing of a definitive agreement in which Celgene will acquire...Read More... The post Celgene set to challenge Incyte and Novartis ...

Results of Phase III RELEVANCE Study Comparing REVLIMID plus Rituximab (R2) Versus Rituximab ...

Celgene CorporationInvestors:+1-908-673-9628ir@celgene.comorMedia:+1-908-673-2275media@celgene.com Read more...

CELGENE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing in Celgene Corporation to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Celgene Corporation ("Celgene" or the "Company") ...

Celgene Moves To Downside On Downgrade By Bernstein

SUMMIT (dpa-AFX) - Shares of Celgene (CELG) have moved notably lower over the course of the trading session on Wednesday, sliding by 2.5 percent.The decline by Celgene comes after Bernstein downgr...

Celgene Seeing Significant Weakness In Afternoon Trading

SUMMIT (dpa-AFX) - Shares of Celgene (CELG) have moved sharply lower during trading on Wednesday, with the biotechnology company slumping by 7.5 percent. Celgene hit its lowest intraday level in o...

Celgene-Aktie: Sind die 65 Millionen US-Dollar für Evotec gut angelegt?

In meiner gestrigen Analyse zu Evotec berichtete ich bereits über die Zusammenarbeit zwischen dem Hamburger Biotechunternehmen und Celgene. Zwar erhält Celgene bei dem Deal die exklusiven Rechte zu....

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Clinical Trials [8 Associated Clinical Trials listed on BioPortfolio]

Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells

This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult subjects exposed to Gene-modified (GM) T cell therapy participating in a p...

Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003

Multi-center, survival data collection in subjects previously enrolled in Celgene Protocol CC-5013-MDS-003.

A Study to Evaluate Long-term Safety in Subjects With Solid Tumors and Hematological Disorders.

Rollover study supporting solid tumor and hematological disorder indications from Celgene sponsored CC-486 protocols eligible for participation in the study.

Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome

To allow patients with HIV-associated wasting to receive thalidomide treatment at 1 of 2 doses. To gain safety and efficacy data from a broader base of patients with HIV-associated wasting...

Spondylitis Trial of Apremilast for Better Rheumatic Therapy

Presently, there are very few treatments available which affect the progression of the disease in the spine. The only proven treatment is the use of drugs inhibiting tumour necrosis factor...

Companies [192 Associated Companies listed on BioPortfolio]

Celgene International Sàrl

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. C...

Celgene Cellular Therapeutics

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. ...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Celgene Corporation

Celgene is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases.Celgene's medical research and devel...

Celgene Corporation and BeiGene, Ltd.

More Information about "Celgene Corporation" on BioPortfolio

We have published hundreds of Celgene Corporation news stories on BioPortfolio along with dozens of Celgene Corporation Clinical Trials and PubMed Articles about Celgene Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celgene Corporation Companies in our database. You can also find out about relevant Celgene Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record